Phase Ib Trial of 177Lu-PSMA-I&T Therapy in Combination With Olaparib and Pembrolizumab in Patients With Metastatic Castration Resistant Prostate Cancer
Clinical trial NCT07090369 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07090369
- Sponsor
- Peter MacCallum Cancer Centre, Australia
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-01
- Primary completion
- 2028-12-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.